Lei Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lei Chen has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Dan-Qian Xu
Zhejiang University of Technology
2 shared publications - Peng Ye
Catalytic Hydrogenation Research Center, State Key Laboratory Breeding Base of Green Chemistry-Synthesis Technology, Key Laboratory of Green Pesticides and Cleaner Production Technology of Zhejiang Province, Zhejiang University of Technology, Hangzhou 310014, P. R. China
2 shared publications - Shao-Jie Lou
Catalytic Hydrogenation Research Center, State Key Laboratory of Green Chemical Synthesis and Conversion, Key Laboratory of Green Pesticides and Cleaner Production Technology of Zhejiang Province, Zhejiang University of Technology, Hangzhou 310014, P. R. China
2 shared publications - Yang-Jie Mao
Zhejiang University of Technology
2 shared publications Zhen-Yuan Xu
Catalytic Hydrogenation Research Center, State Key Laboratory Breeding Base of Green Chemistry-Synthesis Technology, Key Laboratory of Green Pesticides and Cleaner Production Technology of Zhejiang Province, Zhejiang University of Technology, Hangzhou 310014, P. R. China
2 shared publicationsFu-Xiao Cao
The Second Affiliated Hospital ICU of Wenzhou Medical University 325000 Wenzhou Zhejiang Province
1 shared publication
Latest Publications
- 6 February 2024
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 26 (6) , 3522-3526
Transition-metal-free [3 + 2] cycloaddition of C,N-cycloazomethylimines with in situ formed isocyanates from dioxazolones: a facile synthesis of triazolinones
A novel strategy for synthesizing triazolinone with C,N-cycloazomethylimine and dioxazolone has been developed, in which the isocyanate formed in situ from dioxazolone is employed for cyclization instead of the widely used N-acyl nitrene.
- 6 February 2024
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 26 (6) , 3522-3526
Transition-metal-free [3 + 2] cycloaddition of C,N-cycloazomethylimines with in situ formed isocyanates from dioxazolones: a facile synthesis of triazolinones
A novel strategy for synthesizing triazolinone with C,N-cycloazomethylimine and dioxazolone has been developed, in which the isocyanate formed in situ from dioxazolone is employed for cyclization instead of the widely used N-acyl nitrene.
- 1 November 2023
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (45) , 8979-8983
Z-Selective access to α-trifluoromethyl arylenes through Pd-catalysed fluoroarylation of 1,1-difluoroallenes
A Pd-catalysed Z-selective fluoroarylation of 1,1-difluoroallenes with AgF and various aryl iodides was developed for the first time, constituting an interesting approach for the synthesis of challenging Z-α-trifluoromethyl arylenes.
- 1 November 2023
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (45) , 8979-8983
Z-Selective access to α-trifluoromethyl arylenes through Pd-catalysed fluoroarylation of 1,1-difluoroallenes
A Pd-catalysed Z-selective fluoroarylation of 1,1-difluoroallenes with AgF and various aryl iodides was developed for the first time, constituting an interesting approach for the synthesis of challenging Z-α-trifluoromethyl arylenes.
- 7 August 2023
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 10 (18) , 4637-4642
Fluoroarylation of gem -difluorostyrenes through a Pd-catalysed aryl C–H bond activation cascade
A novel fluoroarylation of gem -difluorostyrenes with AgF and (hetero)arenes through a Pd( ii )-catalysed C(aryl)–H activation cascade was developed, constituting an efficient method to access CF 3 -substituted fluorenes and 1,1-diarylmethanes.
- 7 August 2023
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 10 (18) , 4637-4642
Fluoroarylation of gem -difluorostyrenes through a Pd-catalysed aryl C–H bond activation cascade
A novel fluoroarylation of gem -difluorostyrenes with AgF and (hetero)arenes through a Pd( ii )-catalysed C(aryl)–H activation cascade was developed, constituting an efficient method to access CF 3 -substituted fluorenes and 1,1-diarylmethanes.
- Open Access
- 4 October 2017
- Published by African Journals Online (AJOL) in Tropical Journal of Pharmaceutical Research
- Vol. 16 (9) , 2185-2190
Evaluation of Epimedium brevicornum Maxim extract for anti-osteoporosis activity in rats
Purpose: To evaluate the therapeutic effect of Epimedium brevicornum Maxim. extract (EBME) on ovariectomy-induced osteoporosis in rats. Methods: The rats were divided into six experimental groups, viz, control (group 1) and five ovariectomy-induced (OVX) groups. The OVX groups include OVX-inducing agent only group (group 2), OVX with 17ß-estradiol (E2, 25 μg/kg/day, group 3), OVX with 60 mg EBME/kg body weight/day (group 4), OVX with 120 mg EBME/kg body weight/day (group 5) and OVX with 240 mg EBME/kg body weight/day (group 6). The treatment started for the OVX groups with a single weekly dose of OVX inducing agent for 4 weeks, followed by oral daily dose of E2 (group 3) or EBME (groups 4, 5 and 6) for another 16 weeks. Bone mineral density (BMD) of the 4th lumber vertebrae (4LV) and right femur of each rat was estimated. BMD determination was preceded by the measurement of the length of the femur and identification of diaphysis (center). Trabecular microarchitecture was assessed via three representative 4LV. The other parameters measured in this study were serum alkaline phosphatase (ALP), urinary calcium (U-Ca), urinary phosphorus (U-P), urinary creatinine (U-SCr) and osteocalcin (OC) levels. Result: The results showed that the BMD decrease induced by OVX in 4LV and femur was significantly mitigated by high dose of EBME. EBME also protected the trabecular microarchitecture against OVXassociated deterioration, evidenced by decreased bone turnover marker levels in 4LV at high EBME dose. Trabecular number (Tb-N, 3.7 ± 0.2), trabecular thickness (Tb-Th, 0.082 ± 0.011), and trabecular spacing (Tb-Sp, 0.17 ± 0.01) of the highest dose EBME-treated OVX rats ’4LV were significantly (p < 0.05) different from the corresponding values of EBME-free OVX rats. Conclusion: The results reveal that administration of high doses of EBME lasting for 16 weeks not only protected against OVX-induced osteoporosis in rats but was also without the risk of endometrial hyperplasia. Thus, the extract may be a better alternative to other agents in current use for the treatment of postmenopausal osteoporosis in elderly women. However, its efficacy and safety require further investigations. Keywords: Epimedium brevicornum Maxim., Postmenopausal osteoporosis, Ovariectomy, Bone mineral density
- 4 October 2017
- Published by African Journals Online (AJOL) in Tropical Journal of Pharmaceutical Research
- Vol. 16 (9) , 2185-2190
Open AccessEvaluation of Epimedium brevicornum Maxim extract for anti-osteoporosis activity in rats
Purpose: To evaluate the therapeutic effect of Epimedium brevicornum Maxim. extract (EBME) on ovariectomy-induced osteoporosis in rats. Methods: The rats were divided into six experimental groups, viz, control (group 1) and five ovariectomy-induced (OVX) groups. The OVX groups include OVX-inducing agent only group (group 2), OVX with 17ß-estradiol (E2, 25 μg/kg/day, group 3), OVX with 60 mg EBME/kg body weight/day (group 4), OVX with 120 mg EBME/kg body weight/day (group 5) and OVX with 240 mg EBME/kg body weight/day (group 6). The treatment started for the OVX groups with a single weekly dose of OVX inducing agent for 4 weeks, followed by oral daily dose of E2 (group 3) or EBME (groups 4, 5 and 6) for another 16 weeks. Bone mineral density (BMD) of the 4th lumber vertebrae (4LV) and right femur of each rat was estimated. BMD determination was preceded by the measurement of the length of the femur and identification of diaphysis (center). Trabecular microarchitecture was assessed via three representative 4LV. The other parameters measured in this study were serum alkaline phosphatase (ALP), urinary calcium (U-Ca), urinary phosphorus (U-P), urinary creatinine (U-SCr) and osteocalcin (OC) levels. Result: The results showed that the BMD decrease induced by OVX in 4LV and femur was significantly mitigated by high dose of EBME. EBME also protected the trabecular microarchitecture against OVXassociated deterioration, evidenced by decreased bone turnover marker levels in 4LV at high EBME dose. Trabecular number (Tb-N, 3.7 ± 0.2), trabecular thickness (Tb-Th, 0.082 ± 0.011), and trabecular spacing (Tb-Sp, 0.17 ± 0.01) of the highest dose EBME-treated OVX rats ’4LV were significantly (p < 0.05) different from the corresponding values of EBME-free OVX rats. Conclusion: The results reveal that administration of high doses of EBME lasting for 16 weeks not only protected against OVX-induced osteoporosis in rats but was also without the risk of endometrial hyperplasia. Thus, the extract may be a better alternative to other agents in current use for the treatment of postmenopausal osteoporosis in elderly women. However, its efficacy and safety require further investigations. Keywords: Epimedium brevicornum Maxim., Postmenopausal osteoporosis, Ovariectomy, Bone mineral density